KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Retained Earnings (2016 - 2026)

Amgen has reported Retained Earnings over the past 18 years, most recently at -$190.0 million for Q1 2026.

  • For Q1 2026, Retained Earnings rose 99.3% year-over-year to -$190.0 million; the TTM value through Mar 2026 reached -$190.0 million, up 99.3%, while the annual FY2025 figure was -$258.0 million, 99.06% up from the prior year.
  • Retained Earnings for Q1 2026 was -$190.0 million at Amgen, up from -$258.0 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$126.0 million in Q3 2023 and troughed at -$29.6 billion in Q1 2022.
  • A 5-year average of -$9.8 billion and a median of -$544.0 million in 2025 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: plummeted 20161.9% in 2024 and later skyrocketed 99.3% in 2026.
  • Year by year, Retained Earnings stood at -$231.0 million in 2022, then decreased by 25.11% to -$289.0 million in 2023, then tumbled by 9446.71% to -$27.6 billion in 2024, then soared by 99.06% to -$258.0 million in 2025, then increased by 26.36% to -$190.0 million in 2026.
  • Business Quant data shows Retained Earnings for AMGN at -$190.0 million in Q1 2026, -$258.0 million in Q4 2025, and -$422.0 million in Q3 2025.